As an example, satisfactory results of regional infusions: intraperitoneal and intrahepatic delivery (via percutaneous hepatic artery) of anti-carcinoembryonic antigen (CEA) CAR-T cells, in appropriate colorectal cancer metastases in phase I clinical trials have been reported [163,164]. Here, CEACAM5 is linked to colorectal cancer.